Form 8-K - Current report:
SEC Accession No. 0001104659-25-028830
Filing Date
2025-03-27
Accepted
2025-03-27 17:17:01
Documents
16
Period of Report
2025-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510708d1_8k.htm   iXBRL 8-K 30521
2 EXHIBIT 99.1 tm2510708d1_ex99-1.htm EX-99.1 9431
7 GRAPHIC tm2510708d1_ex99-1img001.jpg GRAPHIC 4351
  Complete submission text file 0001104659-25-028830.txt   274668

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA huma-20250327.xsd EX-101.SCH 3680
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE huma-20250327_def.xml EX-101.DEF 27101
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE huma-20250327_lab.xml EX-101.LAB 37598
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE huma-20250327_pre.xml EX-101.PRE 25725
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2510708d1_8k_htm.xml XML 5873
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 25780550
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)